Review





Similar Products

97
ATCC pancreatic cancer cell lines miapaca 2
Pancreatic Cancer Cell Lines Miapaca 2, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pancreatic+cancer+cell+line+miapaca-2/MIA+PaCa-2/us12551498-323-7-36
Average 97 stars, based on 1 article reviews
pancreatic cancer cell lines miapaca 2 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

97
ATCC pancreatic cancer cell pcc lines miapaca 2
a Methodology scheme of tumor formation, CAP treatment and measuring the number of turkey red blood cells 3 days after treatment. Two different PCC and PSC lines were used. b QuPath analysis of the H&E stained tissue sample. The human tumor cells stained intensely blue/purple with hematoxylin and the turkey red blood cells stained intensely pink (left). The turkey red blood cells are indicated in blue after QuPath analysis (green boxes). c Bar plots of the QuPath H&E analysis results, showing the percentage of red blood cells compared to the total number of cells in the tumor. Data is represented as mean ± SD (n ≥ 6 from three independent experiments). d This data is showing the tumor weights per treatment group. Data is represented as mean ± SD (n ≥ 16 from five independent experiments). BH = BxPC-3 + hPSC21 tumor; MR <t>=</t> <t>MiaPaCa-2</t> + RLT-PSC tumor; UT = untreated. Each dot represents one egg. Statistics were performed in GraphPad using one-way ANOVA or Kruskal-Wallis test after the removal of significant outliers (GraphPad Software v10.1.0). *p ≤ 0.05; **p ≤ 0.01.
Pancreatic Cancer Cell Pcc Lines Miapaca 2, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pancreatic+cancer+cell+line+miapaca-2/MIA+PaCa-2/pmc12827977-152-2-8
Average 97 stars, based on 1 article reviews
pancreatic cancer cell pcc lines miapaca 2 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

97
ATCC pancreatic cancer cell line miapaca 2
a Methodology scheme of tumor formation, CAP treatment and measuring the number of turkey red blood cells 3 days after treatment. Two different PCC and PSC lines were used. b QuPath analysis of the H&E stained tissue sample. The human tumor cells stained intensely blue/purple with hematoxylin and the turkey red blood cells stained intensely pink (left). The turkey red blood cells are indicated in blue after QuPath analysis (green boxes). c Bar plots of the QuPath H&E analysis results, showing the percentage of red blood cells compared to the total number of cells in the tumor. Data is represented as mean ± SD (n ≥ 6 from three independent experiments). d This data is showing the tumor weights per treatment group. Data is represented as mean ± SD (n ≥ 16 from five independent experiments). BH = BxPC-3 + hPSC21 tumor; MR <t>=</t> <t>MiaPaCa-2</t> + RLT-PSC tumor; UT = untreated. Each dot represents one egg. Statistics were performed in GraphPad using one-way ANOVA or Kruskal-Wallis test after the removal of significant outliers (GraphPad Software v10.1.0). *p ≤ 0.05; **p ≤ 0.01.
Pancreatic Cancer Cell Line Miapaca 2, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pancreatic+cancer+cell+line+miapaca-2/MIA+PaCa-2/pm41151876-33-2-15
Average 97 stars, based on 1 article reviews
pancreatic cancer cell line miapaca 2 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

99
ATCC human pancreatic cancer cell lines miapaca 2
a Methodology scheme of tumor formation, CAP treatment and measuring the number of turkey red blood cells 3 days after treatment. Two different PCC and PSC lines were used. b QuPath analysis of the H&E stained tissue sample. The human tumor cells stained intensely blue/purple with hematoxylin and the turkey red blood cells stained intensely pink (left). The turkey red blood cells are indicated in blue after QuPath analysis (green boxes). c Bar plots of the QuPath H&E analysis results, showing the percentage of red blood cells compared to the total number of cells in the tumor. Data is represented as mean ± SD (n ≥ 6 from three independent experiments). d This data is showing the tumor weights per treatment group. Data is represented as mean ± SD (n ≥ 16 from five independent experiments). BH = BxPC-3 + hPSC21 tumor; MR <t>=</t> <t>MiaPaCa-2</t> + RLT-PSC tumor; UT = untreated. Each dot represents one egg. Statistics were performed in GraphPad using one-way ANOVA or Kruskal-Wallis test after the removal of significant outliers (GraphPad Software v10.1.0). *p ≤ 0.05; **p ≤ 0.01.
Human Pancreatic Cancer Cell Lines Miapaca 2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pancreatic+cancer+cell+line+miapaca-2/MIA+PaCa-2/pm41023307-349-7-22
Average 99 stars, based on 1 article reviews
human pancreatic cancer cell lines miapaca 2 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

Image Search Results


a Methodology scheme of tumor formation, CAP treatment and measuring the number of turkey red blood cells 3 days after treatment. Two different PCC and PSC lines were used. b QuPath analysis of the H&E stained tissue sample. The human tumor cells stained intensely blue/purple with hematoxylin and the turkey red blood cells stained intensely pink (left). The turkey red blood cells are indicated in blue after QuPath analysis (green boxes). c Bar plots of the QuPath H&E analysis results, showing the percentage of red blood cells compared to the total number of cells in the tumor. Data is represented as mean ± SD (n ≥ 6 from three independent experiments). d This data is showing the tumor weights per treatment group. Data is represented as mean ± SD (n ≥ 16 from five independent experiments). BH = BxPC-3 + hPSC21 tumor; MR = MiaPaCa-2 + RLT-PSC tumor; UT = untreated. Each dot represents one egg. Statistics were performed in GraphPad using one-way ANOVA or Kruskal-Wallis test after the removal of significant outliers (GraphPad Software v10.1.0). *p ≤ 0.05; **p ≤ 0.01.

Journal: NPJ Precision Oncology

Article Title: Short cold atmospheric plasma treatment preserves vascular quiescence in 3D tumor-stroma-endothelial models of pancreatic cancer in vitro and in ovo

doi: 10.1038/s41698-025-01241-9

Figure Lengend Snippet: a Methodology scheme of tumor formation, CAP treatment and measuring the number of turkey red blood cells 3 days after treatment. Two different PCC and PSC lines were used. b QuPath analysis of the H&E stained tissue sample. The human tumor cells stained intensely blue/purple with hematoxylin and the turkey red blood cells stained intensely pink (left). The turkey red blood cells are indicated in blue after QuPath analysis (green boxes). c Bar plots of the QuPath H&E analysis results, showing the percentage of red blood cells compared to the total number of cells in the tumor. Data is represented as mean ± SD (n ≥ 6 from three independent experiments). d This data is showing the tumor weights per treatment group. Data is represented as mean ± SD (n ≥ 16 from five independent experiments). BH = BxPC-3 + hPSC21 tumor; MR = MiaPaCa-2 + RLT-PSC tumor; UT = untreated. Each dot represents one egg. Statistics were performed in GraphPad using one-way ANOVA or Kruskal-Wallis test after the removal of significant outliers (GraphPad Software v10.1.0). *p ≤ 0.05; **p ≤ 0.01.

Article Snippet: The human pancreatic cancer cell (PCC) lines MiaPaCa-2 (ATCC, Manassas, VA, USA) and BxPC-3 (ATCC, Manassas, VA, USA) were used in this study.

Techniques: Staining, Software